Select region
Submit
MAC Brain illustration

 

 

A monitoring tool for general anesthesia

Due to pharmacokinetics, there is a time delay in agent concentrations between the lungs and the target organ, the brain. MAC Brain is a unique feature that uses mathematical models and data-driven algorithms to visualize the difference and act as a decision-support framework to help guide anesthetic dosing.[1]

How MAC Brain works

The image shows the interface of Flow Family anesthesia machines.
The end-tidal MAC and MAC brain are found in the lower left corner of the screen (marked with a green frame). The interface snapshot was taken during induction, when the difference between the two values is often the highest.

MAC Brain is visualized on screen using an algorithm based on basic research and pharmacokinetic models. The option is included in the 4.7 software. 

MAC Brain Flow Family anesthesia

More innovations for our anesthesia machines

With our flow anesthesia technology you can easily ensure the perfect flow for each patient, finetuning anaesthesia delivery in real time, breath by breath.

O2Guard Anesthesia Flow

O₂Guard

Lung recruitment Flow Anesthesia

Lung recruitment

Ventilation Anesthesia Flow

Ventilation performance

Disclaimer

The products, availability of the Flow Family anesthesia systems and SW version may be pending regulatory approvals to be marketed in your country. Contact your Getinge representative for more information. The assertions stated by the physician are strictly those of the physician and do not necessarily reflect the views of Getinge.

⚠ CAUTION: Federal (US) law restricts these devices to sale by or on the order of a physician. Refer to Instructions for Use for current indications, warnings, contraindications, and precautions. 

Getinge US Sales, LLC, One Geoffrey Way, Wayne, New Jersey, United States, 07470

Legal Manufacturer · Maquet Critical Care AB · Röntgenvägen 2 SE-171 54 Solna · Sweden · +46 (0)10 335 73 00

  1. 1. ECRI. The MAC Brain feature on Getinge anesthesia units: ECRI’s view. Device Evaluation 2022 Jan5